Bujko, M.; Zalewski, K.; Szczyrek, M.; Kowalik, A.; Boresowicz, J.; Długosz, A.; Goryca, K.; Góźdź, S.; Kowalewska, M.
Circulating Hsa-miR-431-5p as Potential Biomarker for Squamous Cell Vulvar Carcinoma and Its Premalignant Lesions. Diagnostics 2021, 11, 1706.
https://doi.org/10.3390/diagnostics11091706
AMA Style
Bujko M, Zalewski K, Szczyrek M, Kowalik A, Boresowicz J, Długosz A, Goryca K, Góźdź S, Kowalewska M.
Circulating Hsa-miR-431-5p as Potential Biomarker for Squamous Cell Vulvar Carcinoma and Its Premalignant Lesions. Diagnostics. 2021; 11(9):1706.
https://doi.org/10.3390/diagnostics11091706
Chicago/Turabian Style
Bujko, Mateusz, Kamil Zalewski, Martyna Szczyrek, Artur Kowalik, Joanna Boresowicz, Angelika Długosz, Krzysztof Goryca, Stanisław Góźdź, and Magdalena Kowalewska.
2021. "Circulating Hsa-miR-431-5p as Potential Biomarker for Squamous Cell Vulvar Carcinoma and Its Premalignant Lesions" Diagnostics 11, no. 9: 1706.
https://doi.org/10.3390/diagnostics11091706
APA Style
Bujko, M., Zalewski, K., Szczyrek, M., Kowalik, A., Boresowicz, J., Długosz, A., Goryca, K., Góźdź, S., & Kowalewska, M.
(2021). Circulating Hsa-miR-431-5p as Potential Biomarker for Squamous Cell Vulvar Carcinoma and Its Premalignant Lesions. Diagnostics, 11(9), 1706.
https://doi.org/10.3390/diagnostics11091706